2026-10-25 (in press) / 最終更新日時 : 2026-10-25 wp-admin カルシウム受容体作動薬/calcimimetics

Real-World Outcomes of Oral Calcimimetics, Evocalcet and Cinacalcet, for Chronic Kidney Disease–Mineral and Bone Disorder Management in Hemodialysis Patients in Japan

Nakagawa Y, Onishi Y, Joki N, Kurita N, Fukuma S, Noma H, Wang J, Komaba H, Honda H.
Real-World Outcomes of Oral Calcimimetics, Evocalcet and Cinacalcet, for Chronic Kidney Disease–Mineral and Bone Disorder Management in Hemodialysis Patients in Japan
Kidney Medicine 2026; (in press)
キーワード
カルシウム受容体作動薬/calcimimetics、シナカルセト/cinacalcet、バイオマーカー/biomarker、透析/dialysis、骨・ミネラル代謝異常/MBD
年度
2026年
分野
内分泌・代謝学/endocrinology & metabolism、腎臓病学/nephrology
腰痛/low back pain

前の記事

Adult attention-deficit hyperactivity disorder symptoms are associated with chronic low back pain: A nationwide cross-sectional study of 2,113 individuals
2026-10-01 (in press)